by Harvey Mogojwe | Aug 5, 2021
TB program point-of-care testing was leveraged for HIV viral load and early infant diagnosis testing. Many national testing and treatment programs have traditionally been “vertical” in nature – focused on one disease alone – and have relied on processing tests in...
by Harvey Mogojwe | Aug 3, 2021
In 2011, the HPTN 052 trial demonstrated that people living with HIV who initiated treatment earlier – also referred to as early access to antiretroviral therapy (ART) for all – were less likely to transmit the virus to partners. Adoption of this approach meant that...
by Harvey Mogojwe | Jul 27, 2021
Hepatitis C (HCV) affects more than 58 million people worldwide, and a significant number of people with the disease will progress to chronic disease, liver cancer, and death. Although HCV is curable in more than 95 percent of patients with direct-acting antivirals...
by Harvey Mogojwe | Jul 15, 2021
Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI. Please tell us a bit about your background and what brought you to CHAI. I studied economics and finance at Newcastle University in the UK and proceeded to master in...
by Harvey Mogojwe | Jul 8, 2021
Members of groups particularly at risk of HIV were interviewed to better understand their experiences with facilities that initiated them on PrEP and the factors that helped them adhere to treatment. South Africa has one of the largest burdens of HIV in the world,...
